Stay updated on Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site’s displayed revision label changes from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-21T16:39:27.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The record presents details of the completed Phase 2 study of nivolumab alone or with ipilimumab for resectable hepatocellular carcinoma, including its design, participant criteria, measured outcomes, and study documents.
    Difference
    60%
    Check dated 2026-11-07T16:38:53.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0 while the study page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T16:45:45.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH website updates and a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T20:21:42.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T20:25:00.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T20:39:23.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.